S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
LON:FEVR

Fevertree Drinks (FEVR) Share Price, News & Analysis

GBX 1,077
-13.00 (-1.19%)
(As of 04:53 PM ET)
Today's Range
1,052
1,086
50-Day Range
1,010
1,207
52-Week Range
947
1,489
Volume
276,032 shs
Average Volume
271,309 shs
Market Capitalization
£1.26 billion
P/E Ratio
8,284.62
Dividend Yield
1.58%
Price Target
GBX 1,360

Fevertree Drinks MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
26.3% Upside
GBX 1,360 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.30mentions of Fevertree Drinks in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
£43.83 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.22 out of 5 stars

FEVR stock logo

About Fevertree Drinks Stock (LON:FEVR)

Fevertree Drinks Plc, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. The company offers Indian, Mediterranean, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; gingers; sodas; cola and lemonades; cocktails; and sparkling soft drinks. It sells its products under Fever-Tree brand name to bars and restaurants. The company was formerly known as Fevertree Topco Limited and changed its name to Fevertree Drinks Plc in October 2014. Fevertree Drinks Plc was founded in 2004 and is headquartered in London, the United Kingdom.

FEVR Stock Price History

FEVR Stock News Headlines

Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
15 Fever-Tree Mixers, Ranked
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Drink spike victim had bank account hacked
See More Headlines
Receive FEVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fevertree Drinks and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Beverages - Non - Alcoholic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
300
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 1,360
High Stock Price Target
GBX 1,500
Low Stock Price Target
GBX 1,200
Potential Upside/Downside
+26.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
£15.40 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£364.40 million
Cash Flow
GBX 85.01 per share
Book Value
GBX 204 per share

Miscellaneous

Free Float
N/A
Market Cap
£1.26 billion
Optionable
Not Optionable
Beta
1.09
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Timothy Daniel Gray Warrillow (Age 49)
    Co-Founder, CEO & Executive Director
    Comp: $561.5k
  • Mr. Andrew J. Branchflower (Age 45)
    CFO & Executive Director
    Comp: $361.5k
  • Ms. Ann Hyams
    Director of Investor Relations
  • Mr. Oliver Winters
    Director of Communications
  • Saskia Stoop (Age 40)
    Marketing Director
  • Mr. Alexander James O'Connell
    Company Secretary

FEVR Stock Analysis - Frequently Asked Questions

Should I buy or sell Fevertree Drinks stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fevertree Drinks in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FEVR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FEVR, but not buy additional shares or sell existing shares.
View FEVR analyst ratings
or view top-rated stocks.

What is Fevertree Drinks' stock price target for 2024?

3 analysts have issued 12-month price targets for Fevertree Drinks' stock. Their FEVR share price targets range from GBX 1,200 to GBX 1,500. On average, they anticipate the company's share price to reach GBX 1,360 in the next twelve months. This suggests a possible upside of 26.3% from the stock's current price.
View analysts price targets for FEVR
or view top-rated stocks among Wall Street analysts.

How have FEVR shares performed in 2024?

Fevertree Drinks' stock was trading at GBX 1,049 at the beginning of 2024. Since then, FEVR stock has increased by 2.7% and is now trading at GBX 1,077.
View the best growth stocks for 2024 here
.

How often does Fevertree Drinks pay dividends? What is the dividend yield for Fevertree Drinks?

Fevertree Drinks announced a dividend on Tuesday, March 26th. Stockholders of record on Thursday, May 16th will be given a dividend of GBX 10.90 per share on Friday, June 21st. This represents a dividend yield of 1.01%. The ex-dividend date of this dividend is Thursday, May 16th. This is a positive change from the stock's previous dividend of GBX 5.74. The official announcement can be seen at this link.
Read our dividend analysis for FEVR
.

Is Fevertree Drinks a good dividend stock?

Fevertree Drinks (LON:FEVR) pays an annual dividend of GBX 17 per share and currently has a dividend yield of 1.39%. The dividend payout ratio is 13,076.92%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for FEVR.

What other stocks do shareholders of Fevertree Drinks own?
How do I buy shares of Fevertree Drinks?

Shares of FEVR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:FEVR) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners